Trial · NCT07914413
Foot Drop Rehabilitation and Mobility in Chronic Stroke
NCT07914413, Not applicable, Not yet recruiting, Umm Al-Qura University
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Foot Drop Rehabilitation and Mobility in Chronic Stroke. Trials, record NCT07914413. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07914413
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Foot Drop Rehabilitation and Mobility in Chronic Stroke
- NCT number
- NCT07914413
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 40 participants, estimated
- Lead sponsor
- Umm Al-Qura University
- Conditions
- Stroke
- Interventions
- Conventional Physical Therapy Program, FES-Assisted Gait Training
- First posted
- 2026-11-03
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in the gait parameter (stride length). | Data will be collected at baseline, and after 8 weeks (after finishing the treatment program). | An electronic walkway that connected to a portable computer will be used to measure the following gait parameter: stride length (m). |
| Primary | Change in the gait parameter (stride time). | Data will be collected at baseline, and after 8 weeks (after finishing the treatment program). | An electronic walkway that connected to a portable computer will be used to measure the following gait parameter: stride time (second). |
| Primary | Change in the gait parameter (velocity). | Data will be collected at baseline, and after 8 weeks (after finishing the treatment program). | An electronic walkway that connected to a portable computer will be used to measure the following gait parameter: velocity (meter / second). |
| Primary | Change in the Overall Stability Index {percentage value (%)} for Limit of Stability Test (test that assess the change in balance ability) | Data will be collected at baseline, and after 8 weeks (after finishing the treatment program). | The Biodex Balance System will be used to assess the change in the Overall Stability Index. This test involves measurement of overall directional control which represented as a percentage value (%). The higher scores will indicate better balance control. |
| Primary | Change in functional independence in activities of daily living, and quality of life will be assessed using the Barthel Index. | Data will be collected at baseline, and after 8 weeks (after finishing the treatment program). | Change in functional independence in activities of daily living and quality of life, will be assessed using the Barthel Index. Higher scores indicate greater independence. |
| Primary | Change in the Overall Stability Index {Time of Control (seconds)} for Limit of Stability Test (test that assess the change in balance ability) | Data will be collected at baseline, and after 8 weeks (after finishing the treatment program). | The Biodex Balance System will be used to assess the change in the Time of Control of the Limit of Stability Test. This test involves measurement of total time required to complete the test (seconds), improvement in this parameter requires minimizing the time recorded to complete the test. |
| Secondary | The change in the six-minute walk test score. | Data will be collected at baseline, and after 8 weeks (after finishing the treatment program). | The six-minute walk test (6MWT) will assess the distance that the participant's ability to walk for a total of six minutes on a hard, uneven surface. It has been used to determine exercise tolerance changes following interventions for healthy older adults. |
| Secondary | Change in the score of fall risk test . | Data will be collected at baseline, and after 8 weeks (after finishing the treatment program). | The Biodex Balance System will be used to assess changes in the Overall Stability Index (OSI) during the Fall Risk Test. The results for each participant will be recorded and compared with the age-specific normative data available in the device software for children. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07914413
GET https://conductscience.org/api/trials/v1/NCT07914413/registered